NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023 17:01 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Participate in Upcoming Investor Conferences
August 24, 2023 16:05 ET
|
NeuroPace, Inc.
- Wells Fargo 2023 Healthcare Conference - - Morgan Stanley 21st Annual Global Healthcare Conference - - Lake Street Capital Markets 7th Annual Best Ideas Growth Conference - MOUNTAIN VIEW, Calif.,...
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 08, 2023 16:03 ET
|
NeuroPace, Inc.
Second quarter 2023 revenue of $16.5 million increased 62% year-over-year Full-year revenue guidance increased to $59-$61 million, up from $52-54 million Cash burn reduced to $4 million in the...
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 19, 2023 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Announces CEO Transition
June 28, 2023 16:03 ET
|
NeuroPace, Inc.
NeuroPace Appoints Joel Becker as President & CEO Becker Brings a Track Record of Strong Commercial Execution and Deep Medical Device Operating Expertise Mike Favet to leave Company after four...
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
May 24, 2023 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 04, 2023 16:05 ET
|
NeuroPace, Inc.
First quarter 2023 revenue increased 27% year-over-year to $14.5 million Full-year revenue guidance updated on strength of first quarter performance. Now expected to be $52-$54 million, up from...
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
April 17, 2023 16:05 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...